Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07361614

Pilot Testing of a Colorectal Cancer Education Program

The primary objective of this study is to assess the feasibility, acceptability, and preliminary efficacy of a culturally and linguistically targeted, colorectal cancer (CRC) education program to improve CRC screening completion.

Recruiting

Interested in participating?

Request Info

Key information

Age range

45 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

NYU Langone Health

New York, 10016, United States

Location status: Recruiting

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 45-75 years
  • Not guideline concordant (no stool testing for CRC within past 1 year)
  • No colonoscopy in past 10 years; no sigmoidoscopy or CT colonography in past 5 years)
  • Understands English or Chinese languages.
  • Willing and able to consent to participate

Exclusion criteria

  • history of CRC or colectomy

Treatment and study plan

educational program

Behavioral

Culturally and linguistically tailored program consisting of community health worker (CHW)-led education sessions followed by patient navigation (PN) services.

Primary outcomes

  1. CRC screening completion (yes/no)

    Time frame: Month 6

Secondary outcomes

  1. Change in Brief Illness Perception Questionnaire (IPQ-B) score

    Time frame: Baseline, Month 6

    The IPQ-B is a 9-item questionnaire (validated in the Chinese population) that assesses CRC beliefs according to CRC beliefs according to SRM constructs (SRM) constructs. Each item is rated on a scale from 0 (strong disagree) to 10 (strongly agree). Total scores range from 0-90, with higher scores indicating a greater threat and worse perception of illness.

  2. Change in Medicines Questionnaire (BMQ) score

    Time frame: Baseline, Month 6

    The BMQ, validated in the Chinese population, adapted to assess concerns/necessity of CRC screening is a 5 items questionnaire. Items are assessed on a scale from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 5-25, with higher scores indicating positive beliefs about CRC screening.

  3. Change in number of barriers to care

    Time frame: Baseline, Month 6

    Participants re asked to select all that apply to barriers in care: Cost, Transportation, Lack of time, Fear of results, Embarrassment, Lack of trust in doctors, Language barriers, Other. Each item selected is counted, a decrease in the number of items selected indicates reduced barriers to care.

  4. Change in trust in health/community health workers

    Time frame: Baseline, Month 6

    Group-based medical mistrust scale consists of 2 statements of mistrust and 2 statements of trust. Each statement can be answered with 1) Strongly Disagree, 2) Disagree, 3) Neither Agree nor Disagree, 4) Agree, 5) Strongly Agree.

Study contacts

Contact information is provided by the study sponsor or research team.

Angel Mui

CONTACT

[email protected]

646-501-3521

Suzanne Vang

CONTACT

[email protected]

646-501-3684

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jan 23, 2026
Registry last updated
Apr 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.